Fuji Pharma Co., Ltd. (TYO:4554)
Japan · Delayed Price · Currency is JPY 1,720.00
-44.00 (-2.49%)
Oct 2, 2026, 3:30 PM JST
Fuji Pharma Market Cap
Fuji Pharma has a market cap or net worth of 44.93 billion as of October 2, 2026. Its market cap has increased by 24.14% in one year.
Market Cap
44.93B
Enterprise Value
63.87B
Revenue
60.11B
Ranking
n/a
PE Ratio
14.41
Stock Price
1,720.00
ChartMarket Cap Chart
Since December 21, 2005, Fuji Pharma's market cap has increased from 17.38B to 44.93B, an increase of 158.43%. That is a compound annual growth rate of 4.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 44.93B | -2.70% |
| Dec 30, 2025 | 46.17B | 18.77% |
| Dec 30, 2024 | 38.88B | -8.01% |
| Dec 29, 2023 | 42.26B | 70.05% |
| Dec 30, 2022 | 24.85B | -0.36% |
| Dec 30, 2021 | 24.94B | -35.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kissei Pharmaceutical | 158.47B |
| Kaken Pharmaceutical | 145.22B |
| Mochida Pharmaceutical | 112.14B |
| Zeria Pharmaceutical | 86.00B |
| KYORIN Pharmaceutical | 63.08B |
| ASKA Pharmaceutical Holdings | 58.24B |
| Daito Pharmaceutical | 36.91B |
| Mizuho Medy | 32.25B |